BRIEF-Ipsen says its partner, Lexicon Pharmaceuticals, announces positive results from Telestar Phase 3 study

* Ipsen's partner, Lexicon Pharmaceuticals, announces positive results from Telestar Phase 3 study showing that telotristat etiprate is effective in the treatment of carcinoid syndrome caused by neuroendocrine tumors not ade
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.